HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.

AuthorsH M Dhingra, W K Murphy, R J Winn, M N Raber, W K Hong
JournalInvestigational new drugs (Invest New Drugs) Vol. 9 Issue 1 Pg. 69-72 (Feb 1991) ISSN: 0167-6997 [Print] United States
PMID1709153 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • 5,6-dihydro-5-azacytidine
  • Azacitidine
Topics
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic (adverse effects, therapeutic use)
  • Azacitidine (adverse effects, analogs & derivatives, therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Mesothelioma (drug therapy)
  • Middle Aged
  • Pleural Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: